(Q418998)

flurazepam (English)

19 October 2016

C₂₁H₂₃ClFN₃O

1 reference

flurazepam (English)

19 November 2016

CCN(CC)CCN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3F

1 reference

https://www.whocc.no/atc_ddd_index/?code=N05CD01

flurazepam (English)

19 November 2016

30 milligram

route of administration

oral administration

1 reference

reference URL

medical condition treated

1 reference

significant drug interaction

13 December 2016

pethidine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pethidine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

periciazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tramadol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tramadol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-methadone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-methadone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

morphine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

morphine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

oxycodone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

oxycodone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

hydromorphone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

hydromorphone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

dihydrocodeine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

dihydrocodeine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

codeine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

codeine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tapentadol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tapentadol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

buprenorphine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

mirtazapine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fentanyl

1 reference

A reference set of clinically relevant adverse drug-drug interactions

alfentanil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

alfentanil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

alfentanil

hypotension

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sufentanil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sufentanil

hypotension

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(±)-thiopental

1 reference

probably

A reference set of clinically relevant adverse drug-drug interactions

phenobarbital

1 reference

probably

A reference set of clinically relevant adverse drug-drug interactions

primidone

1 reference

probably

A reference set of clinically relevant adverse drug-drug interactions

sodium oxybate

1 reference

A reference set of clinically relevant adverse drug-drug interactions

cognitive disorder

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

hypotension

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sedation

1 reference

A reference set of clinically relevant adverse drug-drug interactions

syncope

1 reference

A reference set of clinically relevant adverse drug-drug interactions

LiverTox likelihood score

LiverTox toxicity likelihood category D

1 reference

8 April 2021

https://www.ncbi.nlm.nih.gov/books/n/livertox/Flurazepam

24 January 2017

0 references

GABAA receptor positive allosteric modulators

1 reference

5 March 2018

hypnotics and sedatives

1 reference

InChI=1S/C21H23ClFN3O/c1-3-25(4-2)11-12-26-19-10-9-15(22)13-17(19)21(24-14-20(26)27)16-7-5-6-8-18(16)23/h5-10,13H,3-4,11-12,14H2,1-2H3

Medical Subject Headings

15 March 2018

1 reference

Medical Subject Headings

15 March 2018

1 reference

Medical Subject Headings

15 March 2018

Flurazepam

0 references

Identifiers

InChI

1 reference

flurazepam (English)

19 November 2016

2 references

flurazepam (English)

19 November 2016

ChEBI release 2020-09-01

CAS Registry Number

17617-23-1

2 references

flurazepam (English)

19 November 2016

https://commonchemistry.cas.org/detail?cas_rn=17617-23-1

8 April 2021

1 reference

Flurazepam (English)

19 November 2016

2 references

flurazepam (English)

19 November 2016

ChEBI ID

5128

mapping relation type

exact match

2 references

ChEBI release 2019-10-02

International Chemical Identifier

InChI

InChI=1S/C21H23ClFN3O/c1-3-25(4-2)11-12-26-19-10-9-15(22)13-17(19)21(24-14-20(26)27)16-7-5-6-8-18(16)23/h5-10,13H,3-4,11-12,14H2,1-2H3

1 reference

FLURAZEPAM (English)

19 November 2016

2 references

inferred from InChIKey

MSBNK-Athens_Univ-AU163101

1 reference

MassBank accession ID

0 references

MSBNK-Athens_Univ-AU163102

0 references

MSBNK-Athens_Univ-AU163103

0 references

MSBNK-Athens_Univ-AU163104

0 references

MSBNK-Athens_Univ-AU163105

0 references

MSBNK-Athens_Univ-AU163107

0 references

MSBNK-Athens_Univ-AU163108

0 references

MSBNK-Athens_Univ-AU163109

0 references

MSBNK-Athens_Univ-AU163110

0 references

MSBNK-Athens_Univ-AU163111

0 references

MSBNK-Athens_Univ-AU163130

0 references

MSBNK-Athens_Univ-AU163131

0 references

MSBNK-Athens_Univ-AU163132

0 references

MSBNK-Waters-WA000811

0 references

MSBNK-Waters-WA000812

0 references

MSBNK-Waters-WA000813

0 references

MSBNK-Waters-WA000814

0 references

MSBNK-Waters-WA000815

0 references

MSBNK-Waters-WA000816

0 references

SPLASH

splash10-014r-0009000000-5a2839fdce5817956437

0 references

splash10-014i-0009000000-ef2f40465f355c7e04c0

0 references

splash10-014i-0049000000-aeef40f08b145e9212fb

0 references

splash10-014i-0392000000-706f2398b20890152e43

0 references

HSDB ID

3085

1 reference

Hazardous Substances Data Bank

28 October 2019

FLURAZEPAM (English)

10 May 2021

2 references

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

DSSTOX compound identifier

0 references

0 references

241-591-7

1 reference

flurazepam (English)

ECHA Substance Infocard ID

19 November 2016

100.037.795

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

27 December 2018

Flurazepam (English)

CAS no.: 17617-23-1 (English)

1 reference

Guide to Pharmacology Ligand ID

Flurazepam (English)

publication date

17 November 2015

7188

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

7188

D03.633.100.079.080.070.348

flurazepam (English)

19 November 2016

Flurazepam

0 references

MeSH concept ID

M0008645

0 references

MeSH tree code

0 references

RxNorm ID

4501

1 reference

flurazepam (English)

19 November 2016

1 reference

Human Metabolome Database ID

HMDB0014828

2 references

based on heuristic

inferred from InChIKey

2 references

flurazepam (English)

19 November 2016

MedlinePlus drug identifier

0 references

1 reference

flurazepam (English)

19 November 2016

0 references

1 reference

1 reference

https://docs.openalex.org/download-snapshot/snapshot-data-format

Flurazepam (English)

19 January 2016

0 references

1 reference

28 October 2013

1 reference

9 July 2020

Microsoft Academic ID

0 references

1 reference

26 January 2022

1 reference

imported from Wikimedia project

2YOE (English)

19 October 2016

1 reference

1 reference

flurazepam (English)

19 November 2016

0 references

WordNet 3.1 Synset ID

03376209-n

1 reference